Melby P C, Ogden G B, Flores H A, Zhao W, Geldmacher C, Biediger N M, Ahuja S K, Uranga J, Melendez M
Medical Service, Audie L. Murphy Division, South Texas Veterans Health Care System, San Antonio, Texas, USA.
Infect Immun. 2000 Oct;68(10):5595-602. doi: 10.1128/IAI.68.10.5595-5602.2000.
Visceral leishmaniasis caused by the intracellular parasite Leishmania donovani is a significant public health problem in many regions of the world. Because of its large genome and complex biology, developing a vaccine for this pathogen has proved to be a challenging task and, to date, protective recombinant vaccine candidates have not been identified. To tackle this difficult problem, we adopted a reductionist approach with the intention of identifying cDNA sequences in an L. donovani amastigote cDNA library that collectively or singly conferred protection against parasite challenge in a murine model of visceral leishmaniasis. We immunized BALB/c mice with plasmid DNA isolated and pooled from 15 cDNA sublibraries ( approximately 2,000 cDNAs/sublibrary). Following systemic challenge with L. donovani, mice immunized with 6 of these 15 sublibraries showed a significantly reduced (35- to 1,000-fold) hepatic parasite burden. Because of the complexity and magnitude of the sequential fractionation-immunization-challenge approach, we restricted our attention to the two sublibraries that conferred the greatest in vivo protection. From one of these two sublibraries, we identified several groups of cDNAs that afforded protection, including a set of nine novel cDNAs and, surprisingly, a group of five cDNAs that encoded L. donovani histone proteins. At each fractionation step, the cDNA sublibraries or the smaller DNA fractions that afforded in vivo protection against the parasite also induced in vitro parasite-specific T helper 1 immune responses. Our studies demonstrate that immunization with sequential fractions of a cDNA library is a powerful strategy for identifying anti-infective vaccine candidates.
由细胞内寄生虫杜氏利什曼原虫引起的内脏利什曼病是世界许多地区的一个重大公共卫生问题。由于其基因组庞大且生物学特性复杂,开发针对这种病原体的疫苗已被证明是一项具有挑战性的任务,迄今为止,尚未鉴定出具有保护作用的重组疫苗候选物。为了解决这一难题,我们采用了一种简化方法,旨在从杜氏利什曼原虫无鞭毛体cDNA文库中鉴定出在小鼠内脏利什曼病模型中能集体或单独提供抗寄生虫攻击保护作用的cDNA序列。我们用从15个cDNA亚文库(每个亚文库约2000个cDNA)中分离并汇集的质粒DNA免疫BALB/c小鼠。在用杜氏利什曼原虫进行全身攻击后,用这15个亚文库中的6个免疫的小鼠肝脏寄生虫负荷显著降低(35至1000倍)。由于连续分级分离 - 免疫 - 攻击方法的复杂性和规模,我们将注意力集中在两个在体内提供最大保护作用的亚文库上。从这两个亚文库中的一个,我们鉴定出了几组具有保护作用的cDNA,包括一组9个新的cDNA,令人惊讶的是,还有一组5个编码杜氏利什曼原虫组蛋白的cDNA。在每个分级分离步骤中,能在体内提供抗寄生虫保护作用的cDNA亚文库或较小的DNA组分也能在体外诱导寄生虫特异性辅助性T细胞1免疫反应。我们的研究表明,用cDNA文库的连续组分进行免疫是鉴定抗感染疫苗候选物的有力策略。